Combined cutaneous tumors with a melanoma component: A clinical, histologic, and molecular study

The low incidence of adverse outcomes suggests that CCT may be more indolent than noncombined tumors. 11q13 amplification in both components supports the theory of dual differentiation from a common progenitor cell.